MedTrace Logo

Evaluation of a Combination of Plants in Anxiety-related Sleep Disorders: Randomized Trial Versus Placebo

NCT04812418 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2023-11-13

No results posted yet for this study

Summary

The objective of this double-blind randomized clinical trial is to compare the effects of a dietary supplement based on eschscholtzia and valerian extracts to a placebo after 28 days of supplementation, in subjects suffering from sleep troubles associated with anxiety.

Conditions

  • Sleep Troubles Associated With Anxiety

Interventions

DIETARY_SUPPLEMENT

Noctesia

3 tablets every day at bedtime with a large glass of water

DIETARY_SUPPLEMENT

Placebo

3 tablets every day at bedtime with a large glass of water

Sponsors & Collaborators

  • Université Catholique de Louvain

    collaborator OTHER

  • PiLeJe

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-29
Primary Completion
2023-05-17
Completion
2023-06-09

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04812418 on ClinicalTrials.gov